Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis
Dennis G. Moledina(Yale University), Chirag R. Parikh(College of Medicine & JNM Hospital), Ivy A. Rosales(Harvard University), Kristin Meliambro(Icahn School of Medicine at Mount Sinai), Robert B. Colvin(Harvard University), Jordan S. Pober(Yale University), Sean Lefferts(Icahn School of Medicine at Mount Sinai), R. Neal Smith(Massachusetts General Hospital), Mark A. Perazella(Yale University), Markus Bitzer(Oregon Health & Science University), Meghan E. Sise(Harvard University), Lloyd G. Cantley(Yale University), Wassim Obeid(Johns Hopkins University), Randy L. Luciano(Yale University), Gilbert Moeckel(Yale University), Kirk N. Campbell(University of Pennsylvania), Michael Kuperman(Arkana Laboratories), Michael Kashgarian(Yale University), F. Perry Wilson(Yale University)
Cited by 73
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k
International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology
|Kidney International|1993|1.5k
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
|American Journal of Transplantation|2014|1.3k